According to reports Gilead Sciences a top maker of HIV drugs will share its intellectual property... According to reports, Gilead Sciences a top maker of HIV drugs will share its intellectual property... Challenge: Provide a high performance insulating roof system for a highly leak sensitive client on a... Challenge: Provide a high performance insulating roof system for a highly leak sensitive client on a... (Arquivo) A empresa de biotecnologia americana Gilead Sciences fabricante do Truvada utilizado no... (Arquivo) A empresa de biotecnologia americana Gilead Sciences, fabricante do Truvada, utilizado no... EPA/Gilead Sciences Η Gilead θα καταβάλει το ποσό των 180 δολαρίων ανά μετοχή της Kite Pharma ποσό... EPA/Gilead Sciences Η Gilead θα καταβάλει το ποσό των 180 δολαρίων ανά μετοχή της Kite Pharma, ποσό... Gilead Sciences Gilead Sciences Bill Wilton is the Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the... Bill Wilton is the Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the... Is it right for pharmaceutical companies to charge patients too high for life saving drugs that they... Is it right for pharmaceutical companies to charge patients too high for life saving drugs that they... Related Articles The Path to the Cure for Heart Disease: A Cell Signaling Pathway Who’s on First?... Related Articles The Path to the Cure for Heart Disease: A Cell Signaling Pathway Who’s on First?... Open Collage in a new Window Email the Collage Loading... Open Collage in a new Window Email the Collage Loading... Open Collage in a new Window Email the Collage Loading... Open Collage in a new Window Email the Collage Loading... Login to post comments Login to post comments Scott Lazerwith Father and Research Scientist II at Gilead Sciences “I really liked it but I love... Scott Lazerwith Father and Research Scientist II at Gilead Sciences “I really liked it but I love... Growing optimism for Gilead Sciences Inc.’s hepatitis C treatment Sovaldi vaulted shares of the... Growing optimism for Gilead Sciences Inc.’s hepatitis C treatment, Sovaldi, vaulted shares of the... Grade Grade Watch how the stock reacts on a test of 75.00; if it closes below this level on a weekly basis then... Watch how the stock reacts on a test of 75.00; if it closes below this level on a weekly basis, then... Open Collage in a new Window Email the Collage Loading... Open Collage in a new Window Email the Collage Loading... ………………………………………………………………………………………….. ARTÍCULOS RELACIONADOS…… ………………………………………………………………………………………….. ARTÍCULOS RELACIONADOS…… Image 1 of / 2 Caption Close Image 1 of 2 Image 2 of 2 Gilead Sciences CEO joins billionaires' ranks... Image 1 of / 2 Caption Close Image 1 of 2 Image 2 of 2 Gilead Sciences CEO joins billionaires' ranks... Challenge: Provide a high performance insulating roof system for a highly leak sensitive client on a... Challenge: Provide a high performance insulating roof system for a highly leak sensitive client on a... IČO: 24268551 Z. KAPITÁL: 200000 Kč SCHRÁNKA:  jxjj5sx DIČ: CZ24268551 Detail DIČ ADRESA: Na strži... IČO: 24268551 Z. KAPITÁL: 200000 Kč SCHRÁNKA:  jxjj5sx DIČ: CZ24268551 , Detail DIČ ADRESA: Na strži... Foto del medicamento Truvada proporcionada por el laboratorio Gilead Sciences. Uncredited AP Tras... Foto del medicamento Truvada proporcionada por el laboratorio Gilead Sciences. Uncredited AP Tras... Exclusive: HCV Cure - Open Letter to Gilead Sciences Order: Reorder Duration: 2:51 Updated: 04 Jun... Exclusive: HCV Cure - Open Letter to Gilead Sciences Order: Reorder Duration: 2:51 Updated: 04 Jun... John C. Martin CEO of Gilead Sciences a pharmaceutical company has set a price of $1000/pill in... John C. Martin, CEO of Gilead Sciences, a pharmaceutical company, has set a price of $1,000/pill in... Börsengang an der NASDAQ im Januar 1992 Nachdem Gilead Sciences unter der technischen Leitung des... Börsengang an der NASDAQ im Januar 1992 Nachdem Gilead Sciences unter der technischen Leitung des... The chatter will probably increase before a bottom takes hold but at this point those closing out... The chatter will probably increase before a bottom takes hold but at this point, those closing out... Dr. Michael Riordan Gilead Sciences founder CEO Chairman interview 1994 Order: Reorder Duration: 3... Dr. Michael Riordan Gilead Sciences founder, CEO Chairman interview 1994 Order: Reorder Duration: 3...
Próxima »
Pesquisa Avançada